Book Building - SME
₹ 47.69 cr
₹ 1229
100
₹ 1,22,900.00
NSE - SME
17-May-2023
19-May-2023
29-May-2023
The Shares of Remus Pharmaceuticals Ltd have now been listed.
Initial public issue of 388000 equity shares of face value of Rs. 10/- each of Remus Pharmaceuticals Limited (RPL or the Company or the Issuer) for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share (the Issue Price) aggregating to Rs. 47.69 crores (The Issue), of which 19500 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share aggregating to Rs. 2.40 crores will be reserved for subscription by market maker to the issue (the Market Maker Reservation Portion). The issue less the market maker reservation portion i.e. net issue of 368500 equity shares of face value of Rs. 10/- each at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share aggregating to Rs. 45.29 crores is herein after referred to as the Net Issue. The issue and the net issue will constitute 26.34% and 25.02%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each.
To Meet Working Capital Requirements. Funding investments for acquisitions & general corporate purposes.
Remus Pharmaceuticals Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - cs@remuspharma.com
Website - https://www.remuspharma.com